In cancer cells, Nrf2 activation therefore has a dual function: neutralization of ROS production and, at the same time, an increase in cancer cell survival and resistance to treatment through the activation of treatment-resistance proteins and oncogenes [30,31]. Here, NFE2L2 is linked to cancer.